508 filings
Page 7 of 26
DEFA14A
bil9e1byd4zs
25 Apr 22
Additional proxy soliciting materials
4:30pm
DEFA14A
iw5d4f0jpoxotile9z
25 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
wlbj h6nxr4
29 Mar 22
OpGen Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:16pm
8-K
6jhc9mof3d58i
3 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:37pm
8-K
o7jsenb5yu5on yex4
10 Jan 22
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business Update
4:32pm
8-K
5jeupbh y5v3
8 Dec 21
OpGen Announces Results of Special Meeting of Stockholders
4:40pm
8-K
q2cii lt2szhl9
30 Nov 21
OpGen Subsidiary Ares Genetics Announces Strategic Database Access Transaction
4:18pm
8-K
0fjz4kto5f6ol0hgppt
12 Nov 21
OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
6:35am
DEFA14A
41a am0pwk
9 Nov 21
Additional proxy soliciting materials
4:50pm
DEFA14A
zhf73ktfj hw
4 Nov 21
Additional proxy soliciting materials
8:23am
8-K
jmx 1vo0a6ej9
4 Nov 21
OpGen Appoints Albert Weber as Chief Financial Officer
8:21am
DEFA14A
502gzw 2w85
4 Nov 21
Additional proxy soliciting materials
7:31am
8-K
1pvx9yyc0ycobvi to
4 Nov 21
Regulation FD Disclosure
7:30am
DEFA14A
lzdcyyxi zszzouz2
29 Oct 21
Additional proxy soliciting materials
10:07am
DEFA14A
7asm2t2
29 Oct 21
Additional proxy soliciting materials
10:05am